| Autor: |
Hendren NS; Divisions of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas; Parkland Health and Hospital System, Dallas, Texas., Carter S; Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, Utah., Rao A; Divisions of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas; Parkland Health and Hospital System, Dallas, Texas., La Hoz RM; Divisions of Infectious Diseases & Geographic Medicine, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas., Cutrell JB; Divisions of Infectious Diseases & Geographic Medicine, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas., Fares M; Department of Radiology, UT Southwestern Medical Center, Dallas, TX., Concejo BÁ; Divisions of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas; Parkland Health and Hospital System, Dallas, Texas., de Lemos JA; Divisions of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas; Parkland Health and Hospital System, Dallas, Texas., Drazner MH; Divisions of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas., Zaha VG; Divisions of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas., Grodin JL; Divisions of Cardiology, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas; Parkland Health and Hospital System, Dallas, Texas. Electronic address: justin.grodin@utsouthwestern.edu. |
| Abstrakt: |
Competing Interests: Declaration of Competing Interest Dr. Grodin receives consultancy fees from Alnylam, AstraZeneca, Pfizer (New York, New York), Eidos/BridgeBio, and Sarepta. Dr. de Lemos has received grant support from Roche Diagnostics and Abbott Diagnostics and consulting fees from Siemen's Health Care Diagnostics, Beckman Coulter, and Quidel. Dr. Cutrell was an unpaid co-investigator on COVID-19 clinical trials sponsored by the NIH, Gilead and Regeneron. Dr. Zaha was supported by a research grant from the Hammon Center for Regenerative Medicine, UT Southwestern Medical Center. Dr. Hendren has received research grant support from Tricog Health. The remaining authors have no competing interests to declare. |
Full Text from ScienceDirect